Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo

Food and Chemical Toxicology

Volumn 50, Issue 9, 2012, Pages 3048-3055

  Lee, Wonhwa ^a,b   Ku, Sae Kwang ^c   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

Barrier integrity; Endothelium; Inflammation; Lipopolysaccharide; Rutin

Indexed keywords

ACETIC ACID; CARBOXYMETHYLCELLULOSE; GALANGIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; ISORHAMNETIN; KAEMPFEROL; LIPOPOLYSACCHARIDE; MYRICETIN; QUERCETIN; RUTOSIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR INFLAMMATION; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; NF-KAPPA B; RUTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864076531     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.06.013     Document Type: Article

References (49)

1. Akeson A.L., Woods C.W. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J. Immunol. Methods 1993, 163:181-185.
2. Bae J.S., Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 2008, 100:101-109.
3. Bae J.S., Rezaie A.R. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 2011, 118:3952-3959.
4. Bae J.S., Yang L., Manithody C., Rezaie A.R. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J. Biol. Chem. 2007, 282:9251-9259.
5. Bae J.S., Yang L., Manithody C., Rezaie A.R. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 2007, 110:3909-3916.
6. Bae J.W., Bae J.S. Barrier protective effects of lycopene in human endothelial cells. Inflamm. Res. 2011, 60:751-758.
7. Branen L., Hovgaard L., Nitulescu M., Bengtsson E., Nilsson J., Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2137-2142.
8. Che W., Lerner-Marmarosh N., Huang Q., Osawa M., Ohta S., Yoshizumi M., Glassman M., Lee J.D., Yan C., Berk B.C., Abe J. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 2002, 90:1222-1230.
9. Chen B.C., Chou C.F., Lin W.W. Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium. J. Biol. Chem. 1998, 273:29754-29763.
10. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann. Periodontol. 2001, 6:30-40.
11. Dudek S.M., Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 2001, 91:1487-1500.
12. Frenette P.S., Wagner D.D. Adhesion molecules-Part 1. N. Engl. J. Med. 1996, 334:1526-1529.
13. Frenette P.S., Wagner D.D. Adhesion molecules-Part II: blood vessels and blood cells. N. Engl. J. Med. 1996, 335:43-45.
14. Frijns C.J., Kappelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002, 33:2115-2122.
15. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
16. Gimbrone M.A. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am. J. Cardiol. 1995, 75:67B-70B.
17. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 2006, 6:508-519.
18. Harrisson J.W., Seltzer B.W., Martin E.W. The spectrophotometric examination and acute toxicity of rutins obtained from Fagopyrum esculentum (buckwheat) and Sophora japonica. J. Am. Pharm. Assoc. Am. Pharm. Assoc. 1950, 39:556-559.
19. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer 1993, 20:21-29.
20. Hopkins S.J. The pathophysiological role of cytokines. Leg. Med. (Tokyo) 2003, 5(Suppl 1):S45-57.
21. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
22. Kazlowska K., Hsu T., Hou C.C., Yang W.C., Tsai G.J. Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentata. J. Ethnopharmacol. 2010, 128:123-130.
23. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 2001, 276:7614-7620.
24. Kim T.H., Bae J.S. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food Chem. Toxicol. 2010, 48:1682-1687.
25. Kim T.H., Ku S.K., Bae J.S. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food Chem. Toxicol. 2011, 50:1118-1123.
26. Kim T.H., Ku S.K., Lee I.C., Bae J.S. Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells. Inflamm. Res. 2012, 61:217-224.
27. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76:560-568.
28. Komarova Y.A., Mehta D., Malik A.B. Dual regulation of endothelial junctional permeability. Sci. STKE 2007, re8.
29. Korkmaz A., Kolankaya D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J. Surg. Res. 2010, 164:309-315.
30. Lacasse C., Turcotte S., Gingras D., Stankova J., Rola-Pleszczynski M. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. Inflammation 1997, 21:145-158.
31. Lee J.D., Huh J.E., Jeon G., Yang H.R., Woo H.S., Choi D.Y., Park D.S. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int. Immunopharmacol. 2009, 9:268-276.
32. Li Y., Schwabe R.F., DeVries-Seimon T., Yao P.M., Gerbod-Giannone M.C., Tall A.R., Davis R.J., Flavell R., Brenner D.A., Tabas I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 2005, 280:21763-21772.
33. Lockyer J.M., Colladay J.S., Alperin-Lea W.L., Hammond T., Buda A.J. Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ. Res. 1998, 82:314-320.
34. Luscher T.F., Barton M. Biology of the endothelium. Clin. Cardiol. 1997, 20(II):3-10.
35. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 1993, 92:1866-1874.
36. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
37. Milde J., Elstner E.F., Grassmann J. Synergistic inhibition of low-density lipoprotein oxidation by rutin, gamma-terpinene, and ascorbic acid. Phytomedicine 2004, 11:105-113.
38. Murakami K., Okajima K., Uchiba M., Johno M., Nakagaki T., Okabe H., Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996, 87:642-647.
39. Raghav S.K., Gupta B., Agrawal C., Goswami K., Das H.R. Anti-inflammatory effect of Ruta graveolens L. in murine macrophage cells. J. Ethnopharmacol. 2006, 104:234-239.
40. Sluiter W., Pietersma A., Lamers J.M., Koster J.F. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J. Cardiovasc. Pharmacol. 1993, 22(Suppl 4):S37-44.
41. Spiecker M., Darius H., Liao J.K. A functional role of I kappa B-epsilon in endothelial cell activation. J. Immunol. 2000, 164:3316-3322.
42. Takeda R., Suzuki E., Satonaka H., Oba S., Nishimatsu H., Omata M., Fujita T., Nagai R., Hirata Y. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 2005, 111:1398-1406.
43. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995, 80:573-582.
44. Toltl L.J., Swystun L.L., Pepler L., Liaw P.C. Protective effects of activated protein C in sepsis. Thromb. Haemost. 2008, 100:582-592.
45. Ulbrich H., Eriksson E.E., Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol. Sci. 2003, 24:640-647.
46. Ushida Y., Matsui T., Tanaka M., Matsumoto K., Hosoyama H., Mitomi A., Sagesaka Y., Kakuda T. Endothelium-dependent vasorelaxation effect of rutin-free tartary buckwheat extract in isolated rat thoracic aorta. J. Nutr. Biochem. 2008, 19:700-707.
47. Wang X., Feuerstein G.Z., Gu J.L., Lysko P.G., Yue T.L. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 1995, 115:89-98.
48. Wu K.K., Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 1996, 47:315-331.
49. Wung B.S., Ni C.W., Wang D.L. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J. Biomed. Sci. 2005, 12:91-101.